Improved lipid-polymer nanoparticle could advance inhalable mRNA medications and vaccines

Many messenger RNA (mRNA) medicines contain tiny fatty spheres, known as lipid nanoparticles, that encode proteins used by the body to treat or prevent a variety of illnesses. But most versions of lipid nanoparticles for the delivery of mRNA don't work for inhalable medications, because the nanoparticles clump together or increase in size when sprayed into the air. Now, researchers at the Massachusetts Institute of Technology have shown that a polymer with repeating units of positively and negatively charged components – called a zwitterionic polymer – can enable mRNA-containing lipid nanoparticles to withstand nebulization (turning a liquid into a mist).